Living Systematic Reviews: What They Are and When to Use Them

A living systematic review is a review that is continuously or periodically updated as new evidence becomes available, rather than conducted once, published, and left static until someone eventually undertakes a full update years later. It is a genuinely different kind of commitment from a standard systematic review, not simply the same methodology repeated on a schedule, and understanding what that commitment actually involves matters before deciding to adopt this approach.

Why living reviews emerged

Standard systematic reviews can become outdated remarkably quickly in fast-moving research areas -- a review current at publication can be missing meaningful new evidence within a year or two, and by the time enough new evidence has accumulated to justify a full update, years may have passed with clinicians and policymakers relying on an increasingly stale evidence synthesis. Living systematic reviews emerged specifically to address this gap in rapidly evolving fields, most visibly used during the COVID-19 pandemic, where the evidence base was shifting on a matter of weeks rather than years, but the approach applies to any research area with a genuinely fast-moving evidence base.

The core methodological commitment

A living systematic review requires the same rigorous protocol, search strategy, screening, and risk-of-bias methodology as a standard systematic review, but with a pre-specified plan for how often the search will be rerun and the review updated -- monthly, quarterly, or triggered by a specific volume of new relevant publications rather than a fixed calendar schedule. This update frequency, and the criteria that trigger it, should be specified in the protocol from the outset, not decided informally as the review team's capacity allows.

Infrastructure this actually requires

Running a living review is meaningfully more resource-intensive than it might initially appear, because each update cycle requires rerunning the full search strategy, screening new records, extracting data from newly eligible studies, reassessing risk of bias, and re-running any meta-analysis -- essentially repeating the full review workflow on a recurring basis rather than as a one-time project. Teams undertaking a living review need a realistic, sustained resourcing plan covering this ongoing workload, not just the capacity to complete the initial review. A living review that quietly stops updating after the first or second cycle, without formal notice, is arguably worse than a standard review that was always presented as a single snapshot in time, since readers may continue relying on it believing it remains current.

Reporting and version control

Each update to a living systematic review should be clearly versioned and dated, with a change log documenting what new evidence was incorporated and whether conclusions shifted as a result. PRISMA reporting extensions and emerging guidance for living reviews increasingly expect this kind of transparent versioning, allowing readers to see not just the current state of the evidence but the trajectory of how conclusions have evolved as new studies accumulated.

Statistical considerations specific to living reviews

Repeatedly updating a meta-analysis as new studies become available introduces a statistical consideration similar to interim analysis in a single clinical trial -- testing for a significant effect repeatedly as data accumulates increases the risk of a false positive finding at some point along the way, purely by chance, even if no true effect exists. Methods borrowed from sequential trial monitoring, including some of the same Trial Sequential Analysis principles used to assess power in standard meta-analyses, are increasingly applied to living reviews specifically to guard against this inflated false-positive risk across repeated updates.

When a living review is genuinely the right choice

A living systematic review is worth the sustained commitment when the evidence base is genuinely fast-moving, when decision-makers need continuously current synthesis rather than a periodic snapshot, and when the review team or organization has realistic capacity to sustain the update cycle for as long as the review remains active, not just for its first iteration. A slower-moving research area, where new relevant evidence emerges only every few years, does not benefit meaningfully from living-review infrastructure, and a standard systematic review with a planned future update is a more proportionate, sustainable choice.

A note on stopping

Living systematic reviews should have an explicit, pre-considered plan for when and how they will eventually stop being actively updated -- whether the evidence base matures and stabilizes, or the team's capacity to sustain updates changes. Communicating this transition clearly, rather than letting a living review quietly go stale without notice, preserves the credibility the format is specifically designed to build.

Platforms supporting living review infrastructure

Several platforms have emerged specifically to support the operational demands of living systematic reviews, including automated or semi-automated search rerunning, machine-learning-assisted screening prioritization to help reviewers triage new records faster, and structured version-tracking for published updates. Covidence and similar platforms have added specific living-review features over time, recognizing that the manual overhead of a fully traditional workflow is often what causes living reviews to stall after their first or second update cycle in practice, even when the original team's intentions and initial resourcing plan were entirely genuine and well-founded.

Funding and governance considerations

Because a living review is an ongoing commitment rather than a single deliverable, funding and institutional support structures that assume a fixed project end date are often a poor fit. Teams considering a living review should secure a funding or resourcing model that explicitly accounts for the recurring nature of the work -- whether through institutional infrastructure funding, a funder specifically supporting living evidence synthesis, or a realistic volunteer commitment with a clearly stated review-and-renew point -- before committing to the format publicly, since an underfunded living review that quietly stalls partway through its intended lifecycle does more genuine, lasting reputational harm to the underlying body of evidence than simply never having attempted continuous, ongoing updating in the first place at all, precisely because readers, journal editors, and downstream clinical guideline developers may keep citing it as genuinely current long after it has quietly, silently stopped being actively maintained behind the scenes without any public notice at all.